Presented at #ASCO26:
In high-risk localized prostate cancer, ADT plus apalutamide led to a pathological complete response or minimal residual disease and 5-year metastasis-free survival in a greater percentage of patients than ADT plus placebo. Full phase 3 PROTEUS trial results: https://t.co/UxXUkYwd8Z
Editorial: A Watershed Moment in the Perioperative Treatment of Prostate Cancer https://t.co/XgeWL3lqy6
@ASCO
I just learned something new today.
Either I'm late to the game (likely), or perhaps other Urologists also don't know this.
Angiotensin II receptor blockers (ARBs) as a class, modestly suppress PSA levels.
Worth knowing.
(thought to downregulate androgen receptor protein expression)
In a randomized study, novice surgeons who used mental imagery before their first bowel anastomosis scored 17.8/28 vs 10.6/28 in controls.
Practice can start before your hands even move.
Big Bend National Park has more bird species than any national park in America, one of the darkest skies on the continent, a river that is older than human memory.
Texas gave America this. And it's worth protecting.
Among men with locally advanced prostate cancer, transdermal estradiol was noninferior to LHRH agonists for 3-year metastasis-free survival and led to a lower incidence of hot flashes but a higher incidence of gynecomastia. Full results of the STAMPEDE-1 and PATCH trials: https://t.co/sKJ6Sr6WiW
🚨 Honored to share our latest publication! Evaluating outcomes across Latino subpopulations with localized prostate cancer
In an analysis of 7,084 patients with PC treated with RALP, we found significant differences in outcomes across Latino subpopulations 🧵
🔵 Mexican patients had higher baseline PSA & shorter 5- and 10-year OS/BCRFS vs. other Latino subgroups
🔵 SCA subpopulation showed better OS vs. Caribbean and Mexican pts
🔵 Higher baseline PSA & prior hormone therapy were independently associated with high-risk disease at presentation among Latino patients
➡️ Findings underscore the need to disaggregate Latino data in oncology research
➡️ Future research integrating socioeconomic determinants is necessary
👏 Grateful with the incredible team at @CityofHopeSurg@CityofHope_GU@ClaytonLauMD@montypal@WesleyYipMD@AbhiTrip87@ReginaBarCar
🔗 https://t.co/Lge8mJe0aY
Grateful to have presented work on long-term outcomes post SSR from @UTSWUrology at @sufuorg winter meeting in PR 🇵🇷
Key takeaway: Sling removal improves symptoms for many patients, with a substantial proportion achieving durable relief without subsequent surgery.
🚨 Scrotal surgery after living kidney donation
@AnnalsofIM
New population-based data from Canada on laparoscopic donor nephrectomy:
👨⚕️ 898 male donors vs 8,980 matched controls
⚠️ Scrotal surgery: 7.8% donors vs 0.2% controls
📈 HR 38.8 for scrotal surgery
⏱ Median time to surgery: ~5 years
💧 >90% were hydrocelectomies
📊 20-yr risk:
Donors: 13.8% (~1 in 8)
Controls: 0.7% (~1 in 143)
Rates were similar regardless of nephrectomy laterality👉it's not just gonadal vein ligation
🔗https://t.co/14aVHuLxTM
🚀 Largest prospective SABR cohort in inoperable RCC. Pooled FASTRACK trials show 98% local control at 5 years, excellent CSS, low ≥G3 toxicity and no late safety signals. A durable, non‑invasive, kidney‑sparing option—now poised for randomized comparison vs surgery. #EAU26
New work in @jpurology via @DDalela
In pre-pubertal torsion, testicular loss (orchiectomy + ≥50% atrophy) approached 82% among boys with follow-up, even when the testis was initially salvaged.
https://t.co/1F4HoPRecg
The concept of opioids as especially effective pain medications is mythology and is only true in settings where very high doses can be used (PACU, ICU, procedural sedation/analgesia, hospice, etc)
At doses used in ED/floors/outpatient, NSAIDs and acetaminophen are as effective or better than opioids, even for severe/acute pain (kidney stones, injuries including fractures, post-op pain)
You should not be afraid to give opioids to patients who need them, but if you put in oxy for a patient before they are taking scheduled tylenol/ibuprofen you are *under-treating* their pain, not relieving their suffering
https://t.co/PRm0hs4fCq
https://t.co/o6ANrYDAEh
https://t.co/MEGWQSogB4
Surgery is a "wicked" environment: feedback is delayed, noisy, and often biased. My essay on why experience doesn't always equal mastery, and how to learn when the feedback loops are broken.
https://t.co/mkHMtpskBV
#MedTwitter#Surgery#MedEd
🎉It’s a Match!🎉
Please help us extend a big #Buckeye welcome to our incoming PGY1 class!
We are thrilled to have matched such a stellar group, and we can’t wait to have you here soon!
O-H-!
#UroMatch#AUAMatch#Match2026#UroRes
Take a look at the @OSUWexMed's new University Hospital, which opens later this month! It is the largest single facilities project ever undertaken at the university, serving the community at #OSUCOM and beyond. 🌟 https://t.co/kDCSinhXLW